Breakthrough study tests which drug better prevents dangerous surgery leaks
NCT ID NCT03000946
Summary
This study tested whether one drug (somatostatin) works better than another (octreotide) at preventing serious leaks after pancreas surgery. Researchers enrolled 655 patients who were having pancreas surgery to directly compare these two medications. The goal was to find which drug more effectively reduces this common and dangerous complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin Hospital
Paris, Paris, 75014, France
-
La Pitié Salpêtrière Hospital
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.